Korea's regulator approved Hanmi Pharmaceutical's efpeglenatide, the first homegrown GLP-1 obesity drug, after patients lost 9.02% of body weight in 40 weeks. That is less than Wegovy and Mounjaro showed in longer trials, so Hanmi's case rests on milder side effects and a price for long-term patients that it has not yet set.
Reality
- Evidence55
- Adoption8
- Hype gap+15
- Incentives55
- Confidence60
Seoul High Court gave Genencell founder Kang four years in prison, reversing his acquittal over 600 million won paid to a broker's company. The ruling rests on recorded calls tying that money to an approach to Rep. Kim Seung-won.
Reality
- Evidence55
- Adoption
- Insufficient
- Hype gap+10
- Incentives65
- Confidence60
Seoul High Court jailed Genencell founder Kang for four years, ruling that 600 million won paid to a broker was compensation for lobbying via a lawmaker. The ruling contradicts one of the two reasons prosecutors gave in 2024 for suspending the indictment of lawmaker Kim Seung-won.
Reality
- Evidence62
- Adoption
- Insufficient
- Hype gap+20
- Incentives60
- Confidence58
Emocog's route into Korean clinics is now a drugmaker's sales force. The three-year exclusive covers hospitals, clinics and public health centers nationwide, and the screening test that feeds the prescriptions goes with it.
Reality
- Evidence44
- Adoption48
- Hype gap+18
- Incentives70
- Confidence52
Korea's Anti-Corruption and Civil Rights Commission analysed 2,184 startup complaints filed over twelve months and found offers of paid access among the most common, with monthly volumes running 36.5% above the earlier pace.
Reality
- Evidence58
- Adoption
- Insufficient
- Hype gap+20
- Incentives55
- Confidence55
Cosmax made 86.22 million units in July, its highest month this year and about triple its July 2021 output. First-quarter production came to 116% of the preceding fourth quarter, a ratio that stood at 91% in 2022.
Reality
- Evidence58
- Adoption70
- Hype gap+28
- Incentives52
- Confidence55
A Seoul investigation team wanted justice minister nominee Kim Seung-won prosecuted and sentenced to eight months over a request to speed a COVID-19 trial approval. The Supreme Prosecutors' Office suspended the indictment instead.
Reality
- Evidence42
- Adoption
- Insufficient
- Hype gap+12
- Incentives68
- Confidence38
The Korea Consumer Agency says the category's main selling point describes a compound chemically identical to prescription melatonin, and 58 of 100 ads it reviewed were misleading.
Reality
- Evidence46
- Adoption52
- Hype gap+24
- Incentives68
- Confidence41